Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07203625 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours

Study acronym: OPTION-2
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 506 to 316
    • Eligibility criteria expanded, about 31 words
    • Secondary endpoints revised (9)
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary and study completion dates: Mar 31, 2027 to Dec 31, 2027
    • Start date changed from estimate of Nov 1, 2025 to Jan 20, 2026
    • Eligibility criteria revised
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Xuanwu Hospital, Beijing
204 trials monitored
See 3 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
This study is designed to investigate the efficacy and safety of intravenous tenecteplase before interhospital transfer from a non-endovascular capable center(nECC) to an endovascular capable center (ECC) for thrombectomy in patients with acute ischemic stroke (AIS) caused by neuroimaging-confirmed acute basilar artery occlusion (BAO) between 4.5-24 hours of symptom onset.
Trial Details
NCT Number NCT07203625
Lead Sponsor Xuanwu Hospital, Beijing
Conditions
(from sponsor)		 Acute Ischemic Stroke, Basilar Artery Occlusion
Related terms Ischemic Stroke
Enrollment 316 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov